New discovery could be a step towards future immunotherapy for brain cancer
Cancer brain cancer Immunotherapy

New discovery could be a step towards future immunotherapy for brain cancer

Dr M. Sheikh Mohamed
Dr M. Sheikh Mohamed

In 10 seconds? Researchers have found novel structures near brain tumours that can be used to provoke an immune response against cancer cells. This could open the way for more effective treatment with fewer side effects in the future.

What has been found? Scientists call them tertiary lymphoid structures (TLS). They are usually formed at chronic inflammation sites and can be used to trigger our immune system to destroy tumour and virus-infected cells. This is the first report of lymph node-resembling entities in the brain. Interestingly, these TLS were only observed in the tumoural tissue and not in healthy brain tissue of brain cancer patients.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now